Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Cell Reports
|
July 27, 2024
Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans
Julie M Jacobsen, Natalia Petersen, Lola Torz, et al.
Cell Metabolism
|
July 2, 2014
Biphasic effect of melanocortin agonists on metabolic rate and body temperature
Beth Lute, William Jou, Dalya M Lateef, et al.
The AAPS Journal
|
August 28, 2014
A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design
Joanna Z Peng, William S Denney, Bret J Musser, et al.
Nature Metabolism
|
July 8, 2025
CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure
Julie Mie Jacobsen, Jens Frey Halling, Ida Blom, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 3, 2010
Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments
Joseph M Metzger, Karen Gagen, Kate A Raustad, et al.
Molecular Metabolism
|
May 31, 2025
Uncovering the role of Gpr45 in obesity regulation
Eva O Karolczak, Chia Li, Ivan C Alcantara, et al.
The Journal of Clinical Investigation
|
February 23, 2021
Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10
Mariaconcetta Durante, Silvia Squillace, Filomena Lauro, et al.
Journal of Medicinal Chemistry
|
January 4, 2019
Design and in Vivo Characterization of A<sub>1</sub> Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series
Dilip K Tosh, Harsha Rao, Amelia Bitant, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 8, 2008
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity
Richard Berger, Cheng Zhu, Alexa R Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 2019
Quantification of the Capacity for Cold-Induced Thermogenesis in Young Men With and Without Obesity
Robert J Brychta, Shan Huang, Juan Wang, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Cell Reports
|
July 27, 2024
Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans
Julie M Jacobsen, Natalia Petersen, Lola Torz, et al.
Cell Metabolism
|
July 2, 2014
Biphasic effect of melanocortin agonists on metabolic rate and body temperature
Beth Lute, William Jou, Dalya M Lateef, et al.
The AAPS Journal
|
August 28, 2014
A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design
Joanna Z Peng, William S Denney, Bret J Musser, et al.
Nature Metabolism
|
July 8, 2025
CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure
Julie Mie Jacobsen, Jens Frey Halling, Ida Blom, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 3, 2010
Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments
Joseph M Metzger, Karen Gagen, Kate A Raustad, et al.
Molecular Metabolism
|
May 31, 2025
Uncovering the role of Gpr45 in obesity regulation
Eva O Karolczak, Chia Li, Ivan C Alcantara, et al.
The Journal of Clinical Investigation
|
February 23, 2021
Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10
Mariaconcetta Durante, Silvia Squillace, Filomena Lauro, et al.
Journal of Medicinal Chemistry
|
January 4, 2019
Design and in Vivo Characterization of A<sub>1</sub> Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series
Dilip K Tosh, Harsha Rao, Amelia Bitant, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 8, 2008
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity
Richard Berger, Cheng Zhu, Alexa R Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 2019
Quantification of the Capacity for Cold-Induced Thermogenesis in Young Men With and Without Obesity
Robert J Brychta, Shan Huang, Juan Wang, et al.
Page
of 11